טוען...
Rational Combinations of Targeted Agents in AML
Despite modest improvements in survival over the last several decades, the treatment of AML continues to present a formidable challenge. Most patients are elderly, and these individuals, as well as those with secondary, therapy-related, or relapsed/refractory AML, are particularly difficult to treat...
שמור ב:
| הוצא לאור ב: | J Clin Med |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4470160/ https://ncbi.nlm.nih.gov/pubmed/26113989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm4040634 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|